The following symptoms may occur in newborn babies, from mothers who have been treated with Tractiva in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, contact your doctor.
If you are taking Tractiva, your doctor will discuss with you whether you should breastfeed your baby, considering the benefit of your treatment and the benefit of breastfeeding for your baby. If you are being treated with Tractiva, do not breastfeed. Talk toyour doctor about the best way to feed your baby if you are taking this medication.
Driving and operating machinery
During treatment with this medication, dizziness and vision problems (see section 4) may occur. This should be taken into account when requiring maximum attention, for example, when driving or operating machinery.
Tractiva contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
The recommended dose for adults is 15 mg once a day.However, your doctor may prescribe lower and higher doses up to a maximum of 30 mg once a day.
Use in children and adolescents
This medication should be started with the oral solution (liquid) at a low dose.
The dose can be gradually increased tothe recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
If you estimate that the action of aripiprazole is too strong or weak, inform your doctor or pharmacist.
Try to take Tractiva at the same time every day. It does not matter if you take it with or without food.
Take the tablets with water and swallow them whole.
Even if you feel better, do not alter or interrupt the daily dose of aripiprazole without consulting your doctor first.
If you take more Tractiva than you should
If you realize that you have taken more aripiprazole than your doctor recommended (or if someone else has taken part of your aripiprazole), contact your doctor immediately. If you cannot communicate with your doctor, go to the nearest hospital and bring the packaging with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91.562.04.20 indicating the medication and the amount ingested.
Patients who have taken too much aripiprazole have experienced the following symptoms:
• rapid heartbeats, agitation/aggression, language problems;
• unusual movements (especially of the face or tongue) and decreased level of consciousness.
Other symptoms may include:
• acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating;
• muscle rigidity and somnolence, slower breathing, choking, high or low blood pressure, abnormal heart rhythms.
Contact your doctor or nearest hospital immediately if you experience any of the above symptoms.
If you forgot to take Tractiva
If you forget a dose, take the missed dose as soon as you remember, but do not take a double dose to compensate for the missed dose.
If you interrupt treatment with Tractiva
Do not stop treatment just because you feel better. It is essential that you continue taking aripiprazole for the time your doctor has indicated.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Frequent side effects (may affect up to 1 in 10 patients):
Less frequent side effects (may affect up to 1 in 100 patients):
The following side effects have been reported during the post-marketing phase of oral aripiprazole, but the frequency of occurrence is unknown:
Inform your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms.
In elderly patients with dementia, there have been reported a higher number of fatal cases while taking aripiprazole.
Additionally, cases of stroke or "mini" stroke have been reported.
Other side effects in children and adolescents
Adolescents aged 13 years or older experienced side effects similar in frequency and type to those of adults, except for drowsiness, involuntary spasms or contractions, restlessness, and fatigue, which were very frequent (affects more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when getting up after lying down or sitting, which were frequent (affects up to 1 in 10 patients).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medications. By doing so, you will help protect the environment.
Composition of Tractiva
The active ingredient is aripiprazol. Each tablet contains 10 mg of aripiprazol.
The other components are: lactose monohydrate, cornstarch, microcrystalline cellulose, hydroxypropylcellulose, magnesium stearate, and iron oxide red (E172).
Appearance of Tractiva and content of the packaging
Tractiva 10 mg tablets are pink, elliptical, almost flat, with little volume and convex.
Each standard package contains 28 tablets, packaged in blisters.
Holder of the marketing authorization
EXELTIS HEALTHCARE, S.L.
Avda de Miralcampo 7
Polígono Industrial Miralcampo.
19200. Azuqueca de Henares. (Guadalajara)
Spain
Responsible for manufacturing
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande, nº 2, Abrunheira
2710-089 Sintra
Portugal
Last review date of this leaflet:November 2022
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)
http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.